| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.56 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.2 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |